A 34-year-old woman with confusion and visual during pregnancy

New England Journal of Medicine

Volumn 338, Issue 20, 1998, Pages 1448-1456

  Gascon, G G ^a   Frosch, M P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONFUSION; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; ENCEPHALOMYOPATHY; FEMALE; GLOBOID CELL LEUKODYSTROPHY; HUMAN; LEUKODYSTROPHY; MEASLES VIRUS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC DISK; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS; VISUAL IMPAIRMENT;

EID: 0346239960     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199805143382008     Document Type: Article

References (40)

1. Green SH, Wirtschafter JD. Ophthalmoscopic findings in subacute sclerosing panencephalitis. Br J Ophthalmol 1973;57:780-7.
2. Caruso IM, Robbins-Tien D, Brown W, Antony J, Gascon GG. Atypical chorioretinitis as the very first presentation of subacute sclerosing panencephalitis. Neurology 1997;48:Suppl:A286-A287. abstract.
3. Baram TZ, Gonzalez-Gomez I, Xie ZD, et al. Subacute sclerosing panencephalitis in an infant: diagnostic role of viral genome analysis. Ann Neurol 1994;36:103-8.
4. Billeter MA, Cattaneo R, Spielhofer P, et al. Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci 1994;724:367-77.
5. Lombroso CT. Remarks on the EEG and movement disorder in SSPE. Neurology 1968;18:69-75.
6. Brismar J, Gascon GG, von Steyern KV, Bohlega S. Subacute sclerosing panencephalitis: evaluation with CT and MR. AJNR Am J Neuroradiol 1996;17:761-72.
7. McQuaid S, Allen IV, McMahon J, Kirk J. Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: a combined in situ hybridization and immunocytochemical investigation. Neuropathol Appl Neurobiol 1994;20:103-10.
8. Gascon GG, Yamani S, Crowell J, et al. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis. Brain Dev 1993;15:346-55.
9. Gascon GG. Subacute sclerosing panencephalitis. Semin Pediatr Neurol 1996;3:260-9.
10. Sidhu MS, Crowley J, Lowenthal A, et al. Defective measles virus in human subacute sclerosing panencephalitis brain. Virology 1994;202:631-41.
11. Dhib-Jalbut S, Jacobson S, McFarlin DE, McFarland HF. Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis. Ann Neurol 1989;25:272-80.
12. Mehta PD, Thormar H, Kulcyzcki J, Wisniewski HM. Immune response in subacute sclerosing panencephalitis. Ann N Y Acad Sci 1994; 724:378-84.
13. Dawson JR Jr. Cellular inclusions in cerebral lesions of epidemic encephalitis: second report. Arch Neurol Psychiatry 1934;31:685-700.
14. Budka H, Lassmann H, Popow-Kraupp T. Measles virus antigen in panencephalitis: an immunomorphological study stressing dendritic involvement in SSPE. Acta Neuropathol (Berl) 1982;56:52-62.
15. Allen IV, McQuaid S, McMahon J, Kirk J, McConnell R. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J Neuropathol Exp Neurol 1996;55:471-80.
16. Ikeda K, Akiyama H, Kondo H, Arai T, Arai N, Yagishita S. Numerous glial fibrillary tangles in oligodendroglia in cases of subacute sclerosing panencephalitis with neurofibrillary tangles. Neurosci Lett 1995;194:133-5.
17. Nagano I, Nakamura S, Yoshioka M, Kogure K. Immunocytochemical analysis of the cellular infiltrate in brain lesions in subacute sclerosing panencephalitis. Neurology 1991;41:1639-42.
18. Miller C, Farrington CP, Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol 1992;21:998-1006.
19. Griffin DE, Bellini WJ. Measles virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. 3rd ed. Vol. 1. Philadelphia: Lippincott-Raven, 1996:1267-312.
20. Zilber N, Rannon L, Alter M, Kahana E. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE). Neurology 1983; 33:1558-64.
21. Halsey NA, Modlin IF, Jabbour JT, Dubey L, Eddins DL, Ludwig DD. Risk factors in subacute sclerosing panencephalitis: a case-control study. Am J Epidemiol 1980;111:415-24.
22. Tan E, Namer II, Ciger A, Zileli T, Kucukali T. The prognosis of subacute sclerosing panencephalitis in adults: report of 8 cases and review of the literature. Clin Neurol Neurosurg 1991;93:205-9.
23. Thiel A, Nau R, Fischer F, et al. Healthy infant delivered by a mother with subacute sclerosing panencephalitis during pregnancy. Neurology 1996;47:1604.
24. Kabra SK, Bagga A, Shankar V. Subacute sclerosing panencephalitis presenting as cortical blindness. Trop Doct 1992;22:94-5.
25. Kirk J, Zhou A-L, McQuaid S, Cosby SL, Allen IV. Cerebral endothelial cell infection by measles virus in subacute sclerosing panencephalitis: ultrastructural and in situ hybridization evidence. Neuropathol Appl Neurobiol 1991;17:289-97.
26. Hanninen P, Arstila P, Lang H, Salmi A, Panelius M. Involvement of the central nervous system in acute, uncomplicated measles virus infection. J Clin Microbiol 1980;11:610-3.
27. McQuaid S, Kirk J, Zhou A-L, Allen IV. Measles virus infection of cells in perivascular infiltrates in the brain in subacute sclerosing panencephalitis: confirmation by non-radioactive in situ hybridization, immunocytochemistry and electron microscopy. Acta Neuropathol (Berl) 1993;85:154-8.
28. Gerlier D, Varior-Krishnan G, Devaux P. CD46-mediated measles virus entry: a first key to host-range specificity. Trends Microbiol 1995;3:338-45.
29. Buchholz CJ, Gerlier D, Hu A, et al. Selective expression of a subset of measles virus receptor-competent CD46 isoforms in human brain. Virology 1996;217:349-55.
30. Brown HR, Goller NL, Rudelli RD, Dymecki J, Wisniewski HM. Postmortem detection of measles virus in non-neural tissues in subacute sclerosing panencephalitis. Ann Neurol 1989;26:263-8.
31. Ahmed R, Morrison LA, Knipe DM. Persistence of viruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. 3rd ed. Vol. 1. Philadelphia: Lippincott-Raven, 1996:219-49.
32. Fujinami RS, Oldstone MB. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 1979;279: 529-30.
33. Katz M, Koprowski H. The significance of failure to isolate infectious viruses in cases of subacute sclerosing panencephalitis. Arch Gesamte Virusforsch 1973;41:390-3.
34. Hirano A. Subacute sclerosis panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence. J Virol 1992;66:1891-8.
35. Baczko K, Lampe J, Liebert UG, et al. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 1993;197:188-95.
36. Cattaneo R, Schmid A, Rebmann G, et al. Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology 1986;154: 97-107.
37. Cattaneo R, Schmid A, Spielhofer P, et al. Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology 1989;173:415-25.
38. Hirano A, Ayata M, Wang AH, Wong TC. Functional analysis of matrix proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocapsid binding. J Virol 1993;67:1848-53.
39. Schmid A, Spielhofer P, Cattaneo R, Baczko K, ter Meulen V, Billeter M. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology 1992;188:910-5.
40. Cattaneo R, Rose JK. Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol 1993;67:1493-502.